| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1994-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f00243c845ac74a6f5823f44a5998c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b05190d5e86037ca87ed78095ef7484e |
| publicationDate |
1996-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-RE35233-E |
| titleOfInvention |
Method of treating catabolic dysfunction |
| abstract |
The invention relates to a method of treating a catabolic dysfunction in an animal, which comprises administering to an animal a therapeutically effective amount of glutamine, or an analog thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6475514-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922766-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245803-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004081708-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003099722-A1 |
| priorityDate |
1985-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |